IMS-Medical (Artificial Intelligence Massive Screening) was founded by nurse Alberto Martín, who developed an algorithm utilizing artificial intelligence to identify elderly patients at risk of dysphagia. This software, known as AIMS-OD, has already been validated and is being implemented at Mataró Hospital as part of the PECT project «Mataró-Maresme: an innovation ecosystem for caring cities,» funded by the European Union’s Regional Development Funds (FEDER).

The primary focus of IMS-Medical is to enhance the diagnosis of geriatric diseases. As a spin-off of the Consortium, the company has been awarded a grant called «Start-up Capital for Emerging Technological Companies 2023» by the Agency for the Competitiveness of Business of the Generalitat of Catalonia, providing €100,000 to support the company’s business plan for the years 2023-2024.

Their goal is to develop mass screening technologies that empower healthcare professionals to enhance the diagnosis of diseases related to geriatric syndromes. The proposed technology involves a platform for clinical diagnosis support services powered by artificial intelligence.

One of the critical issues to address is the under-diagnosis of dysphagia. Currently, only 20% of hospitalized patients with dysphagia receive proper screening and diagnosis. The existing procedures rely on interviews and questionnaires, which are slow, imprecise, and demand a significant human resource investment. IMS-Medical aims to improve the identification of dysphagia, as well as its major complications, such as aspiration pneumonia and malnutrition, which are often associated with dysphagia.

Article written by Consorci Sanitari del Maresme|Image by Pexels



Consorci Sanitari del Maresme